We are live on
!
Find out more
PTC Therapeutics
PTCT
PTCT
3 hedge funds and large institutions have $3.47M invested in PTC Therapeutics in 2013 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+3
Holders Change %
–
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Alyeska Investment Group
Chicago,
Illinois
| $2.02M | +$2.19M | +135,000 | New |
|
|
SAM
2
Sectoral Asset Management
Montreal,
Quebec, Canada
| $1.29M | +$1.4M | +86,100 | New |
|
|
ICAP
3
Independence Capital Asset Partners
Denver,
Colorado
| $156K | +$169K | +10,400 | New |
|
PTCT Hedge Fund Activity: Q2 2013 in Review
3 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in PTC Therapeutics (PTCT) for Q2 2013, worth a combined $3.47M.
Buyers outnumbered sellers: 3 funds opened new PTCT positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
- 3 institutional investors held PTC Therapeutics (PTCT) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $3.47M of PTC Therapeutics stock for Q2 2013.
- 3 funds opened new PTC Therapeutics positions in Q2 2013 and 0 closed out, a net change of +3 holders.
Based on aggregated 13F filings for Q2 2013.